A stark divergence is emerging at telehealth provider Hims & Hers. The company is aggressively pursuing operational expansion, yet this stands in sharp c ...

Analysts are largely maintaining a "Hold" stance for now. The consensus average price target of $44.90 implies potential upside, but experts appear to be taking a wait-and-see approach. The key ...

Detailed price information for Soundhound Ai Inc Cl A (SOUN-Q) from The Globe and Mail including charting and trades.

Goldman Sachs Group Inc, SPDR® S&P 500® ETF Trust, MGM Resorts International, International Business Machines. Read 's Market Analysis on Investing.com ...

Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...

In a strategic pivot, the company has launched its weight-loss program in the United Kingdom. There, Hims & Hers is offering legitimate, branded medications—Novo Nordisk's Wegovy and Eli Lilly's ...

Hims reports that 70% of Americans believe an economic downturn encourages healthier habits, like cooking at home and ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Hims Hers Health Inc (NYSE:HIMS) stock fell 4.4% Wednesday after U.S. lawmakers introduced legislation that could ...

Here's a look at the top 10 most shorted stocks in the market right now, including Lucid, MARA, Kohl's and more.

The price/sales TTM, EV/Sales TTM, and EV/EBITDA TTM of Novo, as compared to its peers, repeat substantially the same story ...

Global markets posted mixed performance in November, marked by shifting supply chains, evolving investor sentiment toward AI and growth technology, and widening divergence between U.S. and non-U.S.